StockData
CareDx, Inc. logo

CareDx, Inc. (CDNA) stock

CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3027% above fair value
$74.44−0.12 (-0.16%)

Close on Nov 18, 2026Market cap $3.91BP/E 31.1Yield –

CareDx gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

CareDx's gross profit for the twelve months ending Jun 30, 2020 was $98.19M, up 59.7% year over year. For fiscal 2019 it was $81.61M, up 87.3% from the year before. The highest annual figure on record is $81.61M in fiscal 2019.

Annual gross profit

PeriodPeriod endValueChange
FY2019Dec 31, 2019$81.61M+87.3%
FY2018Dec 31, 2018$43.58M+61.7%
FY2017Dec 31, 2017$26.95M-11.3%
FY2016Dec 31, 2016$30.39M+8.0%
FY2015Dec 31, 2015$28.14M+3.1%
FY2014Dec 31, 2014$27.31M+109.7%
FY2013Dec 31, 2013$13.02M+4.0%
FY2012Dec 31, 2012$12.52M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2020Jun 30, 2020$26.78M+34.3%
Q1 FY2020Mar 31, 2020$25.99M+59.9%
Q4 FY2019Dec 31, 2019$23.11M+77.7%
Q3 FY2019Sep 30, 2019$22.32M+81.5%
Q2 FY2019Jun 30, 2019$19.94M+87.8%
Q1 FY2019Mar 31, 2019$16.25M+37.9%
Q4 FY2018Dec 31, 2018$13.00M–
Q3 FY2018Sep 30, 2018$12.30M+21.3%
Q2 FY2018Jun 30, 2018$10.62M+7.6%
Q1 FY2018Mar 31, 2018$11.78M+27.3%
Q4 FY2017Dec 31, 2017-$2.31M-132.9%
Q3 FY2017Sep 30, 2017$10.14M–
Q2 FY2017Jun 30, 2017$9.87M–
Q1 FY2017Mar 31, 2017$9.26M–
Q4 FY2016Dec 31, 2016$7.03M–

More CareDx figures

See a number that looks wrong?